Delivery Order SPE2DB24D9223-SPE2DB25FKEGH
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $5,136.66 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml autoinjector on July 18, 2025. This firm fixed-price delivery order, with an ultimate completion date of August 8, 2025, was issued without set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL. The award...
- The Defense Logistics Agency awarded a delivery order valued at $8,561.10 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/mL auto-injectors, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order was issued on July 21, 2025, without a set-aside designation. The delivery location is Park Ridge, Illinois, where DMS Pharmaceutical Group Inc. maintains its operations as a woman-owned small business pharmaceutical wholesaler. The award represents...
- The Defense Logistics Agency awarded a $12,841.65 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on July 24, 2025, for the supply of Xolair 150 mg/mL auto-injector medication. The contract, which must be completed by August 14, 2025, carries no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,547.40 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml syringes. The award, issued on September 2, 2025, with an ultimate completion date of September 23, 2025, is structured as a firm fixed-price delivery order without any set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this order for delivery to...
- The Defense Logistics Agency awarded a delivery order valued at $5,136.69 to DMS Pharmaceutical Group Inc. on August 25, 2025, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a continuation of the agency's pharmaceutical supply chain operations. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a...
- The Defense Logistics Agency awarded a delivery order valued at $10,273.32 to DMS Pharmaceutical Group Inc. for XOLAIR 150 mg/ml auto-injector, with an ultimate completion date of October 20, 2025. This firm fixed-price delivery order was issued without a set-aside designation on September 26, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will perform the work at its facility in Park Ridge, IL 60068. The company...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $1,712.22 to DMS Pharmaceutical Group Inc. for the supply of Xolair 150 mg/ml auto-injectors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, will fulfill this delivery order with a completion date of September 29, 2025. This award carries no set-aside designation, allowing the vendor to compete directly in the federal procurement...
- The Defense Logistics Agency awarded a $3,424.46 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. on September 25, 2025, for the supply of Xolair 300 mg/2 ml auto-injector prefilled syringes. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will deliver the product to the same location by the October 17, 2025 completion date. This delivery order was issued without a set-aside designation, allowing the contractor to...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector vials. This firm fixed-price delivery order, issued on August 26, 2025, with an ultimate completion date of September 17, 2025, carries no set-aside designation. DMS Pharmaceutical Group is performing at its Park Ridge facility and delivering...
- The Defense Logistics Agency awarded a delivery order valued at $3,424.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 300 mg/2 ml auto-injector units. This firm fixed-price delivery order, issued on September 3, 2025, with completion targeted for September 24, 2025, represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The company,...
- SPE2DB24D9223Indefinite Delivery Contract
- SPE2DB24D9223-SPE2DB25FKEGHDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,561.10 to DMS Pharmaceutical Group Inc. on May 27, 2025, for the supply of Xolair 150 mg/mL auto-injectors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its facility in Park Ridge. The award represents a firm fixed-price delivery order with an ultimate completion date of June 17, 2025, and was made without a set-aside designation, allowing the contractor to compete on an open basis. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.999 billion agreement valid through November 2026. The IDC enables DLA to procure a comprehensive portfolio of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Defense Department healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain through consistent contract performance and a robust portfolio of pharmaceutical product deliveries to military and federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 5/27/25 |